135 related articles for article (PubMed ID: 1805408)
1. [The immediate results of using plasmapheresis in patients with chronic glomerulonephritis].
Dorofeev SB; Tov NL; Movchan EA; Valentik MF; Sidorova LD
Ter Arkh; 1991; 63(10):119-22. PubMed ID: 1805408
[TBL] [Abstract][Full Text] [Related]
2. [The clinical efficacy of plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and nephrotic syndrome].
Kolesnik NA; Dudar' IA; Velichko MB
Urol Nefrol (Mosk); 1993; (6):44-6. PubMed ID: 8160322
[TBL] [Abstract][Full Text] [Related]
3. [The treatment potentials of plasmapheresis in glomerulonephritis].
Malakhovskiĭ IuE; Makarets BG; Dantsiger DG; Dobroliubov EE; Korotenko VA; Erikov AL
Ter Arkh; 1991; 63(6):118-22. PubMed ID: 1948726
[TBL] [Abstract][Full Text] [Related]
4. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
[TBL] [Abstract][Full Text] [Related]
5. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
Ratner MIa; Fedorova ND
Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
[TBL] [Abstract][Full Text] [Related]
6. [Plasmapheresis in the combined therapy of patients with chronic glomerulonephritis and the nephrotic syndrome].
Kolesnyk MO; Velychko MB; Dudar IO
Lik Sprava; 1992 Oct; (10):52-4. PubMed ID: 1485447
[TBL] [Abstract][Full Text] [Related]
7. [The effect of therapeutic plasmapheresis on the hemostatic system of patients with chronic glomerulonephritis and the nephrotic syndrome].
Kolesnyk MO; Lapchyns'ka II; Dudar IO; Velychko MB
Lik Sprava; 1993; (2-3):79-81. PubMed ID: 8191743
[TBL] [Abstract][Full Text] [Related]
8. [The usefulness of plasmapheresis in a case of nephrotic syndrome in Berger's disease].
Pergolini M; Coppotelli L; Paradiso M; Mammarella A; Boccia P; Leonardo M; Basili S; Pettirossi G; Paoletti V; Cordova C
Clin Ter; 1996 Nov; 147(11):543-7. PubMed ID: 9264907
[TBL] [Abstract][Full Text] [Related]
9. [The use of plasmapheresis in the combined treatment of patients with unstable stenocardia].
Mal'ginov SV; Zaruba AIu; Kutsenko AI; Eliseev AO; Rakhmedov DR; Kukharchuk VV
Ter Arkh; 1991; 63(10):131-3. PubMed ID: 1805411
[TBL] [Abstract][Full Text] [Related]
10. [Plasmapheresis in the treatment of rapidly progressing glomerulonephritis].
Milovanov IuS; Komiagin IuV; Nikolaev AIu
Ter Arkh; 1993; 65(6):27-30. PubMed ID: 8378842
[TBL] [Abstract][Full Text] [Related]
11. [Tubulointerstitial component of chronic glomerulonephritis. Clinico-morphological comparisons].
Tov NL; Valentik MF; Vakulin GM; Kagalovskaia IM; Sasin AV
Ter Arkh; 1985; 57(6):32-6. PubMed ID: 4071409
[TBL] [Abstract][Full Text] [Related]
12. [Plasmapheresis in the combined therapy of progressive forms of glomerulonephritis].
Moskaleva ES; Ignatova MS; Korneeva VA; Muromtsev IuV; Tsvetkova EI; Parubinovskaia NM; Kharina EA; Katysheva OV; Krivonos AV
Ter Arkh; 1994; 66(6):42-5. PubMed ID: 7940367
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of chronic glomerulonephritis with ultrahigh doses of cyclophosphane].
Krasnova TN; Shilov EM; Ivanov AA; Samoĭlov DV; Gordovskaia NB; Miroshnichenko NG; Tareeva IE
Ter Arkh; 1991; 63(6):115-8. PubMed ID: 1948725
[TBL] [Abstract][Full Text] [Related]
14. [Plasma separation as an effective treatment of glomerulonephritis in lupus erythematosus].
Michalk D; Scharf J; Waldherr R
Klin Padiatr; 1983; 195(6):418-21. PubMed ID: 6656170
[TBL] [Abstract][Full Text] [Related]
15. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
[TBL] [Abstract][Full Text] [Related]
16. [Cyclophosphamide efficacy in maintenance therapy of nephrotic syndrome in patients with chronic glomerulonephritis].
Ter Arkh; 2004; 76(9):26-8. PubMed ID: 15532372
[TBL] [Abstract][Full Text] [Related]
17. The advantages of immunosuppressive therapy in renal disease.
Zucchelli P
Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
[TBL] [Abstract][Full Text] [Related]
19. [Clinico-laboratory pattern and effectiveness of glucocorticoid therapy of patients with primary diffuse mesangioproliferative glomerulonephritis].
Diadyk AI; Dikshteĭn EA; Vasilenko IV; Siniachenko OV; Kobets VG
Ter Arkh; 1987; 59(8):35-7. PubMed ID: 3686443
[TBL] [Abstract][Full Text] [Related]
20. [The clinico-laboratory effects of acupuncture in patients with glomerulonephritis].
Holub TI
Lik Sprava; 1999 Jun; (4):157-61. PubMed ID: 10476672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
